Unknown

Dataset Information

0

Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplasmic reticulum stress.


ABSTRACT: OBJECTIVES:Meloxicam, a selective cyclooxygenase-2 (COX-2) inhibitor, has been demonstrated to exert anti-tumour effects against various malignancies. However, up to now, mechanisms involved in meloxicam anti-hepatocellular carcinoma effects have remained unclear. MATERIALS AND METHODS:Cell viability and apoptosis were assessed by CCK-8 and flow cytometry. Endoplasmic reticulum (ER) stress and autophagy-associated molecules were analysed by western blotting and immunofluorescence assay. GRP78 and Atg5 knock-down by siRNA or chemical inhibition was used to investigate cytotoxic effects of meloxicam treatment on HCC cells. RESULTS:We found that meloxicam led to apoptosis and autophagy in HepG2 and Bel-7402 cells via a mechanism that involved ER stress. Up-regulation of GRP78 signalling pathway from meloxicam-induced ER stress was critical for activation of autophagy. Furthermore, autophagy activation attenuated ER stress-related cell death. Blocking autophagy by 3-methyladenine (3-MA) or Atg5 siRNA knock-down enhanced meloxicam lethality for HCC by activation of ER stress-related apoptosis. In addition, GRP78 seemed to lead to autophagic activation via the AMPK-mTOR signalling pathway. Blocking AMPK with a chemical inhibitor inhibited autophagy suggesting that meloxicam-regulated autophagy requires activation of AMPK. CONCLUSIONS:Our results revealed that both ER stress and autophagy were involved in cell death evoked by meloxicam in HCC cells. This inhibition of autophagy to enhance meloxicam lethality, suggests a novel therapeutic strategy against HCC.

SUBMITTER: Zhong J 

PROVIDER: S-EPMC6496225 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplasmic reticulum stress.

Zhong Jingtao J   Dong Xiaofeng X   Xiu Peng P   Wang Fuhai F   Liu Ju J   Wei Honglong H   Xu Zongzhen Z   Liu Feng F   Li Tao T   Li Jie J  

Cell proliferation 20151020 6


<h4>Objectives</h4>Meloxicam, a selective cyclooxygenase-2 (COX-2) inhibitor, has been demonstrated to exert anti-tumour effects against various malignancies. However, up to now, mechanisms involved in meloxicam anti-hepatocellular carcinoma effects have remained unclear.<h4>Materials and methods</h4>Cell viability and apoptosis were assessed by CCK-8 and flow cytometry. Endoplasmic reticulum (ER) stress and autophagy-associated molecules were analysed by western blotting and immunofluorescence  ...[more]

Similar Datasets

| S-EPMC5669883 | biostudies-literature
| S-EPMC5571976 | biostudies-literature
| S-EPMC5636985 | biostudies-literature
| S-EPMC9188615 | biostudies-literature
| S-EPMC6325734 | biostudies-literature
| S-EPMC4695050 | biostudies-literature
| S-EPMC8875608 | biostudies-literature
| S-EPMC9745173 | biostudies-literature
| S-EPMC6038181 | biostudies-literature
| S-EPMC6435987 | biostudies-literature